No definition available.
Tibial collateral bursitis [Pellegrini-Stieda]
EFO MESH Endpoint Browser PheWeb
M13_TIBIALCOLLATERAL
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
406 |
4. Check minimum number of eventsNone |
406 |
5. Include endpointsNone |
406 |
6. Filter based on genotype QC (FinnGen only) |
406 |
Control definitions (FinnGen only)
- Control exclude
- M13_DORSOPATHY
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M76
- Name in latin
- Bursitis anserina
Similar endpoints
↥List of similar endpoints to
Tibial collateral bursitis [Pellegrini-Stieda]
based on the number of shared cases.
Similar with more cases:
- Enthesopathies of lower limb, excluding foot
- Soft tissue disorders
- Dorsopathies
- Diseases of the musculoskeletal system and connective tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2376 | 1534 | 838 |
| Only index persons | 2289 | 1496 | 793 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.02 |
| Only index persons | 0.05 | 0.05 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 51.13 | 54.01 | 45.92 |
| Only index persons | 50.96 | 53.82 | 45.56 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 406 | 284 | 122 |
| Unadjusted period prevalence (%) | 0.08 | 0.10 | 0.05 |
| Median age at first event (years) | 53.92 | 55.12 | 51.13 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 358
- Matched controls
- 3578
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M76.4
ICD-10 Finland
Tibial collateral bursitis [Pellegrini-Stieda]
15441.0
323.0
326
*
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
24.5
40.8
58
28
M48.0
ICD-10 Finland
Spinal stenosis
33.1
37.6
49
17
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
6.8
34.4
96
184
M17.1
ICD-10 Finland
Other primary gonarthrosis
4.8
33.8
136
402
M54.4
ICD-10 Finland
Lumbago with sciatica
7.6
30.0
75
121
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.5
27.5
208
1022
M79.6
ICD-10 Finland
Pain in limb
3.5
26.1
170
735
M25.5
ICD-10 Finland
Pain in joint
3.6
25.3
151
606
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
75.6
25.2
28
*
M01AH05
ATC
etoricoxib; oral
3.2
24.0
244
1426
M54.5
ICD-10 Finland
Low back pain
3.7
23.3
124
445
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
15.9
22.2
36
25
Z3226
NOMESCO Finland
Physiotherapist
3.7
19.2
97
329
M03BC01
ATC
orphenadrine (citrate); systemic
3.5
19.0
103
369
N03AX16
ATC
pregabalin; oral
3.6
18.4
94
321
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
9.1
18.0
38
46
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
14.9
17.6
29
21
M01AB05
ATC
diclofenac; systemic, rectal
2.8
17.5
256
1706
M75.1
ICD-10 Finland
Rotator cuff syndrome
3.3
17.4
103
391
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
52.7
17.2
20
*
M54.9
ICD-10 Finland
Dorsalgia, unspecified
5.7
16.9
50
99
7266C
ICD-9 Finland
Peripheral enthesopathies and allied syndromes, Enthesopathy of knee[TENDINITIS SEU BURSITIS REGIONIS LIG GENUS COLL LAT]
+∞
16.8
16
*
7266B
ICD-9 Finland
Peripheral enthesopathies and allied syndromes, Enthesopathy of knee[TENDINITIS SEU BURSITIS REGIONIS LIG GENUS COLL MED]
+∞
16.8
16
*
M54.1
ICD-10 Finland
Radiculopathy
31.7
16.3
21
7
ZXA05
NOMESCO Finland
Left side
2.9
16.0
118
517
N02AX02
ATC
tramadol; systemic, rectal
2.6
15.4
152
788
N03AX12
ATC
gabapentin; oral
4.2
15.3
61
166
Z3231
NOMESCO Finland
Registered nurse
2.8
15.1
119
542
M19.0
ICD-10 Finland
Primary arthrosis of other joints
4.6
14.9
54
134
N02AJ06
ATC
codeine and paracetamol; systemic
2.6
14.8
147
760
M03BX02
ATC
tizanidine; oral
2.5
14.8
231
1521
N02BE01
ATC
paracetamol; systemic, rectal
3.4
14.6
320
2550
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
16.3
14.6
23
15
L15
ICPC
Knee symptom/complaint
2.9
14.4
100
417
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
4.9
14.4
48
109
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
55.6
13.9
16
*
ZB0.1
ICD-10 Finland
Right side
145.3
13.5
14
*
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
3.5
13.5
68
226
M02AA07
ATC
piroxicam; topical
2.4
13.4
153
844
M76.6
ICD-10 Finland
Achilles tendinitis
7.2
13.3
32
48
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
3.8
13.0
57
168
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
5.8
13.0
37
70
R51.80
ICD-10 Finland
Headache
3.5
12.7
62
200
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.3
12.7
48
124
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
+∞
12.6
12
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.4
12.5
148
824
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
15.0
12.4
20
14
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
7.0
12.3
30
46
M01AE02
ATC
naproxen; oral, rectal
2.2
12.3
213
1416
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.7
11.9
95
426
M01AX05
ATC
glucosamine; oral
2.8
11.9
89
384
R07.4
ICD-10 Finland
Chest pain, unspecified
2.6
11.8
103
487
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
36.3
11.3
14
*
M47.9
ICD-10 Finland
Spondylosis, unspecified
36.3
11.3
14
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.3
11.2
130
709
M54.2
ICD-10 Finland
Cervicalgia
6.9
11.0
27
42
R4110
NOMESCO Finland
Physiotherapy
2.4
10.5
108
550
ZXA00
NOMESCO Finland
Right side
2.4
10.5
110
568
ABC16
NOMESCO Finland
Microsurgical excision of lumbar intervertebral disc displacement
+∞
10.5
10
*
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
+∞
10.5
10
*
P01AB01
ATC
metronidazole; oral, rectal
2.1
10.4
159
973
M70.6
ICD-10 Finland
Trochanteric bursitis
3.3
10.3
54
184
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.3
10.2
38
97
R03AC02
ATC
salbutamol; inhalant
2.1
10.2
192
1280
H02AB06
ATC
prednisolone; systemic
2.1
10.1
170
1079
R42
ICD-10 Finland
Dizziness and giddiness
2.5
10.0
87
406
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
9.6
151
926
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
3.0
9.5
57
210
NGM20
NOMESCO Finland
Excision of synovial ganglion of knee or lower leg
102.6
9.5
10
*
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
4.2
9.5
35
89
7227C
ICD-9 Finland
Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]
+∞
9.4
9
*
NDM20
NOMESCO Finland
Excision of synovial ganglion of wrist or hand
9.1
9.4
19
22
NGF00
NOMESCO Finland
Excision of plica of synovy of knee
8.7
9.2
19
23
M54.3
ICD-10 Finland
Sciatica
8.7
9.2
19
23
R06AE07
ATC
cetirizine; oral
2.0
9.1
161
1032
M01AX17
ATC
nimesulide; oral
2.3
9.0
93
472
R05
ICD-10 Finland
Cough
2.5
8.9
78
363
M67.4
ICD-10 Finland
Ganglion
4.1
8.8
34
90
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
4.9
8.8
28
61
X59
ICD-10 Finland
Exposure to unspecified factor
2.5
8.8
74
335
A02BC02
ATC
pantoprazole; systemic
2.0
8.8
228
1684
M01AH02
ATC
rofecoxib; oral
2.9
8.7
56
217
M76.8
ICD-10 Finland
Other enthesopathies of lower limb, excluding foot
12.0
8.6
15
13
Z50.1
ICD-10 Finland
Other physical therapy
4.2
8.4
31
79
M01AE03
ATC
ketoprofen; systemic, rectal
2.0
8.4
140
870
M01AH01
ATC
celecoxib; oral (coxibs)
2.5
8.3
69
311
1220
FHL
Arthroscopy
5.1
8.2
25
52
ZXD20
NOMESCO Finland
Day surgery
2.6
8.2
61
259
J45.9
ICD-10 Finland
Asthma, unspecified
2.5
7.9
67
307
N05CF01
ATC
zopiclone; oral
2.0
7.8
115
673
J01AA02
ATC
doxycycline; systemic
2.0
7.7
279
2270
N06AX21
ATC
duloxetine; oral
3.2
7.6
40
137
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
7.6
102
573
G44.2
ICD-10 Finland
Tension-type headache
2.7
7.6
51
204
Z2221
NOMESCO Finland
Medical doctor
2.0
7.6
107
617
M79.0
ICD-10 Finland
Rheumatism, unspecified
6.2
7.5
19
32
M01AE01
ATC
ibuprofen; systemic, rectal
2.4
7.5
318
2750
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
81.7
7.4
8
*
M01AC06
ATC
meloxicam; systemic, rectal
1.9
7.4
131
823
ABC26
NOMESCO Finland
Open discectomy of lumbar spine
+∞
7.3
7
*
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.8
7.3
193
1394
M71.2
ICD-10 Finland
Synovial cyst of popliteal space [Baker]
5.0
7.3
22
46
N06AA09
ATC
amitriptyline; systemic
3.2
7.2
37
125
M79.7
ICD-10 Finland
Fibromyalgia
6.8
7.2
17
26
M23.8
ICD-10 Finland
Other internal derangements of knee
5.5
7.2
20
38
L86
ICPC
Back syndrome with radiating pain
5.5
7.2
20
38
L17
ICPC
Foot/toe symptom/complaint
2.1
7.2
89
486
R06.0
ICD-10 Finland
Dyspnoea
2.2
7.2
83
437
L02
ICPC
Back symptom/complaint
3.2
7.1
36
120
A06AC01
ATC
ispaghula (psylla seeds); oral
2.1
7.0
90
498
L14
ICPC
Leg/thigh symptom/complaint
3.7
7.0
29
83
9473
FHL
Local soft tissue removal or exploration (eg Bursa)
14.1
6.9
11
8
A02BC03
ATC
lansoprazole; oral
2.0
6.9
99
570
XA402
NOMESCO Finland
ENMG
6.9
6.9
16
24
WX110
NOMESCO Finland
Local anesthesy
1.8
6.8
243
1912
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.0
6.8
103
605
J01DB01
ATC
cefalexin; oral
2.0
6.7
287
2401
M54.6
ICD-10 Finland
Pain in thoracic spine
4.8
6.7
21
46
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
2.6
6.7
50
214
SAA03
NOMESCO Finland
Extended examination of mouth
1.9
6.7
137
898
M02AA10
ATC
ketoprofen; topical
2.3
6.7
62
296
M77.1
ICD-10 Finland
Lateral epicondylitis
3.2
6.7
33
109
J01EA01
ATC
trimethoprim; systemic
2.0
6.6
95
547
L01
ICPC
Neck symptom/complaint
2.6
6.6
48
201
ZXE00
NOMESCO Finland
One hour or less
1.8
6.6
149
1008
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
4.1
6.5
24
62
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.9
6.5
104
625
B01AB05
ATC
enoxaparin; parenteral
1.9
6.4
108
658
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
2.4
6.4
53
239
H60.9
ICD-10 Finland
Otitis externa, unspecified
3.6
6.4
27
79
L29
ICPC
Musculoskeletal sympt/complt other
3.3
6.3
30
96
L03
ICPC
Low back symptom/complaint
2.2
6.3
68
347
A02BC05
ATC
esomeprazole; systemic
1.8
6.3
138
922
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
6.3
102
613
M22.4
ICD-10 Finland
Chondromalacia patellae
5.5
6.2
17
32
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.8
6.2
166
1181
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
6.2
97
575
WX320
NOMESCO Finland
Spinalanesthesy
2.0
6.2
87
495
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
2.7
6.1
40
159
R03AK07
ATC
formoterol and budesonide; inhalant
2.1
6.0
68
354
S83.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of knee
3.9
6.0
23
62
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3000330) Specific gravity of Urine by Test strip
58
154
4.23
20.09
3.7
3.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
105
434
2.91
18.13
2.9
2.5
e6/l
4.1
2.8
0.38
63
233
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
107
451
2.86
17.79
3.0
2.4
e6/l
0.8
1.2
1.15
64
248
(3014051) Protein [Presence] in Urine by Test strip
27
53
5.39
13.35
1.6
2.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
128
667
2.34
13.24
1.7
1.6
mg/l
1.6
1.2
0.20
99
517
(3030467) Casts [#/volume] in Urine by Automated count
143
794
2.24
12.63
3.1
2.7
e6/l
0.2
0.5
3.00
104
584
(3021601) Nitrite [Presence] in Urine by Test strip
227
1553
2.05
11.21
6.0
4.4
estimate
0.0
0.0
0.50
25
272
(3018095) Leukocytes [#/volume] in Urine
170
1055
2.05
10.93
3.7
3.1
e6/l
40.8
131.0
1.58
115
729
(3002582) Erythrocytes [#/volume] in Urine
150
892
2.08
10.80
3.2
2.7
e6/l
11.9
131.1
0.98
110
683
(3009261) Glucose [Presence] in Urine by Test strip
225
1561
1.99
10.39
4.0
3.2
estimate
0.0
0.0
0.50
26
257
(3002032) Base excess in Venous blood by calculation
59
242
2.68
9.99
3.6
2.6
mmol/l
3.2
1.8
1.42
49
202
(1761482) Bacteria [#/volume] in Urine by Culture
31
87
3.78
9.86
4.8
4.7
—
—
—
0
0
(3012544) pH of Venous blood
60
251
2.63
9.77
3.6
2.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
191
1279
1.93
9.52
3.7
4.2
g/l
35.4
35.8
0.38
183
1197
(3035350) Ketones [Presence] in Urine by Test strip
219
1536
1.92
9.48
3.8
3.2
estimate
0.0
0.0
0.00
27
272
(3021447) Carbon dioxide [Partial pressure] in Venous blood
58
245
2.60
9.25
3.7
2.5
kpa
5.9
5.8
0.12
58
240
(3013707) Erythrocyte sedimentation rate by Westergren method
301
2371
2.04
9.01
4.4
3.6
mm/h
10.8
11.9
0.80
287
2178
(3011397) Hemoglobin [Presence] in Urine by Test strip
114
654
2.03
8.77
3.6
3.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
162
1050
1.90
8.72
3.3
2.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
50
202
2.68
8.70
3.7
2.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
279
2155
1.94
8.66
4.3
3.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
217
1548
1.86
8.62
4.6
5.4
e9/l
0.6
0.6
0.40
177
1347
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
98
535
2.10
8.61
1.5
1.2
iu/ml
17.1
35.2
2.28
32
179
(3013115) Eosinophils [#/volume] in Blood
223
1605
1.86
8.60
4.8
5.8
e9/l
0.2
0.2
0.17
190
1424
(3006315) Basophils [#/volume] in Blood
217
1556
1.85
8.40
4.6
5.4
e9/l
0.0
0.0
0.14
179
1353
(3019198) Lymphocytes [#/volume] in Blood
221
1594
1.85
8.39
4.8
5.4
e9/l
1.8
2.0
0.79
186
1418
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
97
534
2.07
8.30
2.6
3.4
ng/l
148.8
386.3
0.88
72
408
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
305
2448
1.99
8.19
7.1
7.0
u/l
76.2
78.0
0.38
286
2295
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
376
3291
2.93
7.98
16.0
11.6
mg/l
19.2
23.5
1.85
315
2549
(36304419) Bacteria [Presence] in Urine
127
782
1.91
7.85
3.2
2.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
35
127
2.92
7.43
1.9
1.9
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
206
1501
1.76
7.15
4.9
5.3
%
56.8
57.1
0.12
190
1420
(3021589) Normoblasts [#/volume] in Blood
200
1447
1.75
7.10
8.2
8.7
e9/l
0.0
0.0
0.41
157
1192
(3006504) Eosinophils/100 leukocytes in Blood
202
1469
1.75
7.02
4.8
5.4
%
3.0
2.8
0.94
183
1374
(3019069) Monocytes/100 leukocytes in Blood
203
1479
1.75
7.00
5.0
5.7
%
8.6
8.5
0.08
187
1395
(3002030) Lymphocytes/100 leukocytes in Blood
207
1521
1.74
6.89
5.0
5.5
%
27.8
28.1
0.20
189
1426
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
204
1493
1.74
6.89
6.1
6.0
mmol/l
1.2
1.2
0.10
184
1270
(3022096) Basophils/100 leukocytes in Blood
195
1413
1.73
6.79
4.9
5.4
%
0.7
0.7
0.30
179
1319
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
68
352
2.12
6.77
2.3
2.1
umol/l
6.0
8.6
0.75
61
308
(3013826) Glucose [Moles/volume] in Serum or Plasma
234
1789
1.73
6.67
5.1
4.0
mmol/l
6.6
6.7
0.31
220
1674
(3026008) Bacteria identified in Urine by Culture
140
928
1.78
6.64
3.2
2.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
237
1821
1.72
6.61
7.4
9.4
e9/l
4.3
4.1
0.54
197
1593
(3000991) Gas panel - Venous blood
47
211
2.39
6.56
5.3
6.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
120
765
1.81
6.47
2.4
2.4
umol/l
4460.4
6707.8
0.21
99
665
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
88
510
1.93
6.39
1.4
1.3
u/ml
6.1
13.6
1.12
39
194
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
310
2586
1.84
6.33
4.1
3.9
pmol/l
14.8
14.7
0.21
289
2350
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
92
545
1.89
6.24
1.5
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
121
782
1.78
6.19
5.5
6.9
—
—
—
0
0
(3026782) Osmolality of Urine
97
586
1.86
6.19
2.6
2.5
mosm/kgh2o
536.1
555.5
0.31
76
503
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
354
3096
2.12
6.13
5.1
4.6
mu/l
1.8
2.3
0.62
337
2822
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
198
1469
1.68
6.12
3.5
3.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
68
367
2.02
6.03
1.4
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
159
1131
1.67
5.66
4.6
3.3
ng/l
22.3
43.1
1.58
108
769
(3048689) Calprotectin [Mass/mass] in Stool
66
361
1.99
5.63
2.4
2.1
ug/g
156.9
110.1
0.31
55
283
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
260
2098
1.67
5.60
3.1
2.9
—
—
—
0
0
(3044889) 12 lead EKG panel
280
2305
1.69
5.57
4.1
3.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
76
439
1.90
5.53
1.6
1.7
s
31.4
29.1
2.56
76
429
(40761511) CBC panel - Blood by Automated count
383
3493
2.70
5.44
14.4
11.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
25
90
2.89
5.41
1.4
1.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
64
352
1.97
5.37
7.0
6.0
mmol/l
104.5
104.3
0.09
64
335
(42529406) Shigella sp [Presence] in Stool by Culture
25
91
2.86
5.30
1.4
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
209
1618
1.60
5.15
5.3
6.1
umol/l
10.6
11.3
0.58
195
1547
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
33
141
2.46
5.14
1.8
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
35
155
2.38
5.05
1.3
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
70
409
1.86
4.90
1.5
1.4
titre
302.2
510.5
—
9
88
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
24
90
2.77
4.84
1.4
1.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
32
140
2.40
4.75
2.5
2.0
%
1.1
1.3
0.51
32
140
(3042936) Bacteria identified in Isolate by Culture
70
416
1.82
4.63
2.0
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
347
3088
1.85
4.63
18.6
12.8
%
38.0
40.1
2.80
276
2287
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
32
142
2.36
4.61
2.9
2.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
51
276
1.97
4.48
2.2
1.9
u/l
29.0
34.4
0.54
46
240
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
26
106
2.55
4.48
1.7
1.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
363
3292
1.97
4.35
4.7
4.3
mmol/l
6.0
5.9
0.67
347
3013
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
161
1213
1.54
4.22
4.2
3.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
356
3215
1.87
4.22
14.4
11.1
ml/min/173m2
82.3
82.1
0.08
309
2626
(3018418) pH of Serum or Plasma
125
890
1.58
4.20
3.6
3.3
ph
7.4
7.4
0.29
15
173
(3025941) Bacteria identified in Stool by Culture
34
162
2.20
4.17
1.4
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
269
2270
1.55
4.13
2.6
2.8
u/l
43.1
49.4
0.63
255
2133
(42870588) Differential panel, method unspecified - Blood
138
1009
1.56
4.12
4.7
5.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
13
37
3.60
4.08
1.4
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
60
354
1.82
4.06
1.4
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
116
826
1.57
3.86
3.0
3.0
ng/l
1160.3
1074.7
0.13
100
708
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
18
66
2.81
3.80
2.2
2.5
u/ml
0.3
0.4
—
9
41
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
142
1062
1.52
3.77
2.7
3.2
u/l
31.5
33.3
0.16
137
1020
(3035285) Chloride [Moles/volume] in Venous blood
14
45
3.19
3.68
2.3
2.0
mmol/l
106.2
105.9
0.08
14
45
(3033705) Calcium.ionized [Moles/volume] in Venous blood
14
45
3.19
3.68
2.3
2.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
14
45
3.19
3.68
2.3
2.0
mmol/l
4.1
4.0
0.56
14
45
(3008898) HLA-B27 [Presence]
23
98
2.43
3.64
1.1
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
124
907
1.53
3.63
3.4
2.9
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
32
3.51
3.35
1.3
1.3
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
32
166
2.01
3.19
2.2
2.3
e6/l
0.1
0.2
1.06
32
160
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
18
73
2.53
3.17
1.7
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
169
1345
1.44
3.16
2.5
2.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
74
2.50
3.09
1.3
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
153
1201
1.44
3.06
10.8
8.0
inr
1.2
1.2
0.18
31
383
(3021788) Differential panel - Synovial fluid
13
45
2.95
3.05
1.5
1.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
170
1367
1.42
2.96
3.3
2.6
ug/l
90.1
114.6
1.87
164
1263
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
383
3615
2.05
2.92
11.0
9.2
u/l
25.6
25.6
0.00
375
3475
(3019150) Specific gravity of Urine by Refractometry
90
642
1.52
2.90
4.3
3.3
kg/l
1.0
1.0
0.96
17
93
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
22
429
0.48
2.86
4.8
4.0
%
33.5
31.8
0.21
13
283
(3000570) Elastase.pancreatic [Mass/mass] in Stool
19
84
2.32
2.81
1.4
1.4
ug/g
242.1
295.2
—
8
49
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
33
182
1.89
2.79
1.5
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
339
3105
1.56
2.78
6.9
5.3
mmol/mol
39.8
39.5
0.21
320
2883
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
13
48
2.76
2.74
1.5
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
13
48
2.76
2.74
1.1
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
64
429
1.58
2.72
2.3
2.2
umol/l
11.9
12.9
0.58
57
394
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
48
300
1.68
2.68
1.6
1.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
128
993
1.42
2.67
2.0
2.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
32
3.18
2.66
1.3
1.3
nmol/l
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
165
1342
1.39
2.61
6.1
5.1
mmol/l
1.2
1.2
0.12
153
1231
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
36
209
1.79
2.60
1.8
3.1
ng/l
129.3
176.4
0.53
30
189
(40768797) Stomach Pathology biopsy report
62
417
1.57
2.60
1.3
1.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
28
150
1.93
2.59
6.2
7.6
mmol/l
24.0
24.5
0.47
23
142
(3007853) Bacteria identified in Skin by Aerobe culture
51
328
1.63
2.56
2.0
1.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
83
597
1.49
2.56
2.3
2.3
e6/l
3.0
7.0
2.17
68
526
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
45
281
1.68
2.53
1.5
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
21
102
2.12
2.52
2.1
2.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
95
705
1.45
2.51
1.3
1.3
u/ml
0.8
1.4
1.21
23
184
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
121
939
1.41
2.50
2.6
2.3
u/l
57.0
55.1
0.21
112
872
(3007461) Platelets [#/volume] in Blood
393
3772
2.31
2.40
23.6
17.6
e9/l
259.6
254.2
0.93
388
3657
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
49
319
1.61
2.36
2.8
4.7
u/l
256.9
237.1
0.42
43
308
(3000475) Leukocytes [#/volume] in Synovial fluid
14
59
2.42
2.32
1.7
1.6
e6/l
2261.7
30996.7
—
6
43
(3026361) Erythrocytes [#/volume] in Blood
393
3777
2.27
2.30
23.6
17.6
e12/l
4.5
4.5
0.38
387
3653
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
46
298
1.61
2.26
1.7
1.7
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
393
3779
2.25
2.26
23.6
17.7
e9/l
6.7
6.6
0.42
388
3652
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
16
73
2.24
2.24
1.6
1.7
e6/l
87.6
4.3
—
10
54
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
16
73
2.24
2.24
1.7
1.8
e6/l
6.0
100.7
1.55
11
56
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
42
2.66
2.20
1.0
1.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
28
159
1.82
2.20
1.6
1.3
—
—
—
0
0
(4034850)
19
95
2.05
2.14
11.9
6.8
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
10
37
2.75
2.12
1.5
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
93
710
1.40
2.09
2.4
2.0
mg/l
3.1
3.1
0.06
81
606
(3021440) Promyelocytes/100 leukocytes in Blood
39
248
1.63
2.07
3.2
4.3
%
0.6
0.1
—
6
67
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
43
281
1.59
2.05
2.0
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
365
3450
1.57
2.04
5.1
4.6
mmol/l
2.9
2.8
0.36
349
3184
(3044290) Cell count panel - Cerebral spinal fluid
14
63
2.27
2.03
1.5
1.9
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
26
3.12
2.02
1.9
2.5
—
—
—
0
0
(4010399)
34
210
1.68
2.02
1.4
1.3
—
—
—
0
0
(4268621)
9
32
2.85
2.01
2.1
2.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
47
316
1.55
1.99
2.1
1.9
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
21
3.37
1.97
2.9
4.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
36
228
1.64
1.95
3.1
3.0
ng/l
97.2
75.7
0.85
31
203
(3016018) Differential panel - Cerebral spinal fluid
9
34
2.68
1.87
1.6
1.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
146
1218
1.31
1.82
2.3
1.8
pmol/l
94.7
96.2
0.16
78
610
(3023368) Bacteria identified in Blood by Culture
95
745
1.36
1.80
4.1
3.9
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
20
109
1.88
1.80
2.0
1.6
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
23
3.08
1.80
1.0
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
156
1317
1.30
1.77
2.4
2.2
nmol/l
76.0
77.4
0.24
143
1181
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
16
81
2.02
1.77
2.5
2.0
ug/l
668.7
259.9
0.37
16
75
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
104
1.87
1.70
2.7
1.7
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
28
173
1.66
1.69
9.0
7.9
%
0.6
0.7
0.52
28
173
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
73
555
1.38
1.68
2.6
2.8
mmol/l
2.4
2.5
0.56
62
500
(3024891) Influenza virus A+B Ag [Presence] in Specimen
16
83
1.97
1.67
1.1
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
81
630
1.36
1.62
1.5
1.5
g/l
2.4
2.4
0.09
52
391
(3027945) Reticulocytes/100 erythrocytes in Blood
44
308
1.48
1.58
2.3
2.8
%
1.8
1.8
0.19
39
283
(3025130) Human papilloma virus identified in Specimen
10
44
2.30
1.54
1.6
1.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
29
186
1.60
1.53
1.5
1.3
—
45.9
—
0
11
(3017181) Myelocytes/100 leukocytes in Blood
39
269
1.50
1.51
3.3
4.1
%
1.8
0.9
—
6
77
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
21
2.88
1.51
1.2
1.0
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
14
72
1.98
1.50
3.3
1.7
g/l
0.0
0.0
0.00
14
67
(3026389) Candida sp identified in Specimen by Organism specific culture
9
37
2.46
1.49
1.2
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
52
381
1.42
1.48
1.6
1.8
%
1.3
1.4
0.33
45
345
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
14
73
1.95
1.45
1.1
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
59
445
1.38
1.43
1.7
1.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
127
1071
1.27
1.41
3.1
3.3
mmol/l
2.4
2.4
0.32
116
953
(3047007) Chlamydophila sp Ab [Presence] in Serum
9
40
2.28
1.41
1.3
1.1
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
14
74
1.92
1.40
3.3
1.7
g/l
0.0
0.0
0.00
14
68
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
26
167
1.59
1.38
1.6
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
88
710
1.31
1.38
4.1
4.3
ug/l
1.3
2.0
2.76
77
642
(3003396) Base excess in Arterial blood by calculation
45
327
1.42
1.35
8.2
6.6
mmol/l
1.1
1.4
0.19
35
266
(40761535) Cells panel - Urine sediment
31
209
1.52
1.35
4.0
3.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
24
2.52
1.31
1.3
1.3
—
—
—
0
0
(4027681)
5
18
2.80
1.29
1.4
1.1
—
—
—
0
0
(3013512) EKG study
111
931
1.26
1.28
4.9
3.4
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
44
322
1.41
1.28
8.3
6.6
kpa
12.1
12.6
0.27
38
316
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
13
228
0.56
1.28
1.2
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
71
562
1.32
1.27
3.4
3.9
%
21.3
21.2
0.01
21
256
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
26
171
1.56
1.26
9.5
8.0
%
1.2
1.3
0.17
26
171
(3013139) Helicobacter pylori Ag [Presence] in Stool
30
204
1.51
1.26
1.2
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
30
204
1.51
1.26
2.1
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
49
2.07
1.23
1.1
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
66
520
1.32
1.23
1.7
1.7
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
37
2.19
1.22
1.5
2.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
89
734
1.27
1.18
1.8
2.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
11
57
1.96
1.18
1.8
1.9
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
54
418
1.34
1.14
1.4
1.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
11
58
1.92
1.13
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
11
58
1.92
1.13
1.0
1.1
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
14
81
1.75
1.10
3.3
1.7
g/l
0.0
0.0
0.00
14
75
(3000492) Spirometry study
43
323
1.37
1.10
1.5
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
10
52
1.95
1.07
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
10
52
1.95
1.07
1.3
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
34
2.08
1.03
1.1
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
32
231
1.42
1.03
1.8
2.5
ml/min/173m2
72.7
65.5
0.61
15
94
(4306422)
9
47
1.94
1.02
1.1
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
9
47
1.94
1.02
1.4
1.5
%
58.3
60.3
—
9
47
(3019225) pH of Specimen
20
294
0.66
0.99
3.7
4.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
9
49
1.86
0.99
2.1
2.6
%
61.4
57.1
—
9
49
(4094501)
14
84
1.69
0.99
1.3
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
341
3269
1.27
0.99
4.1
3.8
mmol/l
1.4
1.3
1.71
326
2997
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
29
0.00
0.98
0.0
2.5
—
31.3
—
0
7
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
36
1.96
0.97
1.3
1.1
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
31
0.00
0.96
0.0
17.5
—
1688.4
—
0
31
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
31
0.00
0.96
0.0
13.0
—
914.5
—
0
31
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
70
1.74
0.93
2.0
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
11
63
1.77
0.91
1.4
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
6
29
2.08
0.89
1.0
1.0
—
—
—
0
0
(4024509)
6
29
2.08
0.89
1.0
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
29
2.08
0.89
1.3
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
25
178
1.43
0.88
2.4
2.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
352
3398
1.27
0.88
4.6
4.2
mmol/l
4.8
4.8
0.04
337
3152
(36660697) Celiac disease serology panel - Serum
33
249
1.35
0.85
1.3
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
8
46
1.75
0.83
2.0
2.5
e9/l
5.0
4.1
—
8
46
(3019309) Folate [Moles/volume] in Red Blood Cells
64
531
1.24
0.83
1.7
1.7
nmol/l
1090.8
1100.2
0.03
55
399
(3051611) Lipemic interference index of Serum or Plasma
6
32
1.89
0.82
1.7
2.6
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
6
32
1.89
0.82
1.0
1.7
umol/l
2.5
4.3
—
6
19
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
32
1.89
0.82
1.2
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
47
1.72
0.81
1.6
2.7
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
33
1.83
0.79
1.2
1.4
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
14
91
1.56
0.76
1.5
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
29
219
1.35
0.75
1.4
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
102
896
1.18
0.75
1.4
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
54
1.68
0.75
1.1
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
68
576
1.22
0.73
1.4
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
107
0.55
0.73
1.5
1.9
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
7
39
1.81
0.73
1.0
1.0
—
2.2
—
0
10
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
60
1.68
0.72
1.7
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
41
1.72
0.70
1.6
1.6
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
5
27
1.86
0.68
1.0
1.0
—
2.1
—
0
7
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
2.4
1.4
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
5
27
1.86
0.68
4.4
1.7
—
1.9
—
0
14
(3009508) Creatinine [Moles/volume] in Urine
107
953
1.17
0.67
2.9
3.0
mmol/l
7.8
7.5
0.17
85
810
(40760892) CBC W Ordered Manual Differential panel - Blood
84
735
1.18
0.65
4.6
4.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
43
352
1.25
0.64
1.4
1.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
29
1.73
0.64
1.2
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
29
1.73
0.64
1.0
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
12
79
1.53
0.63
1.2
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
24
182
1.34
0.63
2.9
2.1
nmol/l
13.8
12.7
0.32
24
172
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
49
1.65
0.62
1.0
1.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
8
50
1.61
0.61
1.0
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
50
1.61
0.61
1.0
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
20
148
1.37
0.61
1.3
1.3
iu/l
36.1
29.8
0.32
20
129
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
21
0.00
0.60
0.0
3.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
115
0.60
0.58
1.6
2.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
22
167
1.34
0.58
1.1
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
35
1.72
0.58
1.0
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
29
362
0.79
0.58
1.4
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
348
3388
1.19
0.57
4.5
4.1
mmol/l
1.5
1.5
1.94
332
3126
(3012516) Albumin [Mass/volume] in Urine
100
898
1.15
0.56
3.3
3.1
mg/l
21.3
268.2
1.26
58
561
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
49
414
1.21
0.56
2.7
2.6
ug/l
0.6
0.7
0.45
27
256
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
37
1.63
0.55
1.2
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
37
1.63
0.55
1.0
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
107
967
1.14
0.55
4.1
3.8
mg/mmol
2.6
7.3
2.86
61
598
(3017143) Hepatitis C virus Ab [Presence] in Serum
39
324
1.23
0.53
1.4
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
63
1.44
0.52
1.1
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
11
75
1.48
0.51
1.7
1.2
u/l
10.1
10.4
0.03
11
65
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
49
1.44
0.46
1.7
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
51
1.38
0.44
1.7
1.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
15
0.00
0.41
0.0
5.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
16
0.00
0.41
0.0
2.9
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
16
0.00
0.41
0.0
2.9
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
8
59
1.36
0.41
2.0
2.8
kpa
8.2
8.0
—
8
54
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
17
0.00
0.40
0.0
1.2
—
1.1
—
0
5
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
35
1.43
0.39
1.0
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
19
0.00
0.39
0.0
4.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
22
268
0.81
0.38
1.9
3.0
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
36
1.39
0.38
1.0
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
36
1.39
0.38
1.0
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
15
116
1.30
0.37
2.1
1.9
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
37
1.36
0.37
1.0
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
37
1.36
0.37
1.0
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
98
906
1.11
0.36
1.5
1.5
mmol/l
1.5
1.4
0.45
89
755
(40768443) Skin Pathology biopsy report
17
135
1.27
0.36
1.2
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
9
123
0.73
0.35
2.8
3.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
80
0.62
0.35
2.0
1.5
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
43
1.40
0.35
1.2
2.3
pg
33.8
31.8
—
6
43
(3019060) Gas panel - Arterial blood
14
178
0.78
0.35
11.6
4.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
10
73
1.38
0.35
2.0
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
12
92
1.31
0.32
2.8
3.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
13
101
1.30
0.32
1.6
2.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
11
84
1.32
0.30
1.8
1.9
iu/l
2.6
7.8
—
5
29
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
55
1.28
0.30
1.3
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
55
1.28
0.30
1.3
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
55
1.28
0.30
1.9
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
55
1.28
0.30
1.3
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
106
0.75
0.29
1.3
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
57
1.23
0.29
1.3
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
18
149
1.22
0.28
8.2
8.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
64
1.25
0.27
1.0
1.4
—
—
—
0
0
(1002224) Polysomnography panel
19
159
1.20
0.27
1.1
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
27
234
1.16
0.27
1.1
1.3
iu/ml
136.7
151.0
—
8
99
(3003327) Ova and parasites identified in Stool by Light microscopy
14
113
1.25
0.27
2.3
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
26
225
1.17
0.26
2.1
3.2
e9/l
69.4
72.6
0.18
20
172
(3051387) C reactive protein [Mass/volume] in Capillary blood
10
77
1.31
0.26
4.8
4.0
mg/l
28.6
33.6
—
5
48
(3015235) Bicarbonate [Moles/volume] in Capillary blood
9
72
1.26
0.26
1.4
3.0
mmol/l
23.0
26.4
—
9
61
(3029937) Albumin [Presence] in Urine by Test strip
85
796
1.09
0.25
3.7
3.3
estimate
0.0
0.0
0.80
27
270
(3050129) First trimester maternal screen panel - Serum or Plasma
6
83
0.72
0.24
1.5
1.4
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
22.2
—
0
11
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
11
0.00
0.21
0.0
1.1
—
122.9
—
0
11
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
10
0.00
0.21
0.0
2.8
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
10
0.00
0.21
0.0
1.1
—
430.4
—
0
5
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
3.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
43
1.16
0.21
1.6
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
39
355
1.11
0.21
3.0
4.7
ug/l
3.5
20.2
0.77
30
291
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
0
13
0.00
0.21
0.0
1.2
—
103.7
—
0
13
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
10
123
0.81
0.20
1.9
2.5
u/l
44.0
39.2
—
10
115
(3002256) Pathology report gross observation
47
433
1.10
0.20
1.3
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
38
346
1.11
0.20
10.1
5.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
49
1.23
0.20
1.7
1.7
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
6
50
1.20
0.20
1.0
1.9
g/l
0.4
0.9
—
6
37
(3037756) Immunofixation for Serum or Plasma
6
53
1.13
0.18
1.2
1.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
53
1.13
0.18
1.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
58
1.21
0.18
1.4
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
82
1.23
0.17
1.1
1.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
69
1.16
0.16
1.3
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
69
1.16
0.16
1.3
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
69
1.16
0.16
1.3
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
69
1.16
0.16
1.3
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
8
70
1.15
0.16
1.5
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
73
1.10
0.16
1.3
2.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
79
0.76
0.15
2.0
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
118
0.84
0.14
1.5
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
133
1364
0.96
0.11
3.2
2.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
17
153
1.12
0.11
2.4
3.8
mmol/l
2.4
2.5
—
6
125
(3021960) Folate [Moles/volume] in Serum or Plasma
72
693
1.05
0.10
1.6
1.4
nmol/l
19.3
21.4
0.70
66
578
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
48
1.04
0.09
1.0
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
6
54
1.11
0.09
1.5
2.9
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
6
54
1.11
0.09
1.2
1.5
u/l
50.0
30.6
—
6
47
(3020891) Body temperature
12
107
1.13
0.08
11.8
4.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
61
0.82
0.08
1.2
1.7
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
63
0.79
0.08
1.8
1.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
25
234
1.07
0.08
1.8
2.9
g/l
9.1
10.6
1.69
25
216
(40760888) Immunoglobulin light chains.free panel - Serum
5
65
0.77
0.08
7.8
3.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
123
0.89
0.08
1.4
1.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
74
0.81
0.07
1.2
1.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
7
84
0.83
0.07
5.9
3.1
mg/l
26.3
64.5
—
7
64
(3034860) Kappa light chains.free [Mass/volume] in Serum
7
84
0.83
0.07
5.9
3.1
mg/l
56.1
63.1
—
7
64
(3016879) Cocaine [Presence] in Urine
9
84
1.07
0.07
1.2
1.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
9
85
1.06
0.07
12.4
4.3
mmol/l
3.9
3.8
—
9
75
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
8
93
0.86
0.07
1.1
1.2
—
1.9
—
0
7
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
64
659
0.97
0.06
1.5
1.7
pmol/l
388.0
18215375.1
0.78
56
549
(4035726)
31
298
1.04
0.04
1.4
1.4
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
22
210
1.05
0.03
2.0
2.2
u/ml
46.5
57.6
0.14
22
202
(3017732) Neutrophils [#/volume] in Blood
22
211
1.05
0.03
2.2
2.2
e9/l
4.9
4.2
0.40
17
170
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
31
317
0.98
0.01
2.5
2.8
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
33
336
0.98
0.00
1.7
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
25
253
0.99
0.00
1.7
1.6
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
14.8
—
0
6
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
55
0.91
0.00
2.4
2.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.4
—
8.8
—
0
8
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
62
0.97
0.00
1.2
1.5
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.2
—
108.0
—
0
6
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
6
0.00
0.00
0.0
2.8
—
3488.5
—
0
6
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
69
1.01
0.00
1.3
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
58
0.86
0.00
2.0
1.6
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
71.5
—
0
5
(3027944) Amphetamines [Presence] in Urine
9
96
0.94
0.00
1.2
1.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.1
—
18.4
—
0
7
(3022689) Creatine [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
67
0.89
0.00
1.2
1.2
—
1.0
—
0
5
(40758047) Lysozyme [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
5.7
—
0
5
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
13.6
—
0
5
(3028300) Cannabinoids [Presence] in Urine
9
96
0.94
0.00
1.2
1.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
9.3
—
0
5
(3052592) Norovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
9
95
0.95
0.00
1.2
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
66
0.91
0.00
1.7
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
9
96
0.94
0.00
1.2
1.3
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
1.8
—
0
5
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
0.0
—
0
5
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
7
0.00
0.00
0.0
3.7
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
87
0.92
0.00
2.9
2.9
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_TIBIALCOLLATERAL and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_TIBIALCOLLATERAL | 0.731 [0.58, 0.92] | 0.008 |
| Birth year | 0.995 [0.99, 1.0] | 0.297 |
During the follow-up period (1.1.1998 — 31.12.2019), 86 out of 1195 females with M13_TIBIALCOLLATERAL died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_TIBIALCOLLATERAL | 1.153 [0.89, 1.5] | 0.286 |
| Birth year | 0.989 [0.98, 1.0] | 0.031 |
During the follow-up period (1.1.1998 — 31.12.2019), 77 out of 529 males with M13_TIBIALCOLLATERAL died.
Mortality risk
Mortality risk for people of age
years, who have M13_TIBIALCOLLATERAL.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.061% | 0.217% |
| 5 | 0.427% | 1.509% |
| 10 | 1.123% | 3.654% |
| 15 | 2.112% | 6.848% |
| 20 | 3.733% | 12.032% |
Relationships between endpoints
↥Index endpoint: M13_TIBIALCOLLATERAL – Tibial collateral bursitis [Pellegrini-Stieda]
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data